위장관암 환자의 옥살리플라틴 항암화학요법으로 인한 말초신경병증, 증상경험, 디스트레스와 삶의 질

• Published in: Asian oncology nursing Vol. 19; no. 4; pp. 204 - 213
• Main Authors: 정혜정(Jung, Hye Jeong), 안수정(Ahn, Soo jung), 양유리(Yang, Yoo Ri), 김경아(Kim, Kyoung A), 신상준(Shin, Sang Joon), 정민규(Jung, Min Kyu), 추상희(Chu, Sang Hui)
• Format: Journal Article
• Language: Korean
• Published: 대한종양간호학회 01.12.2019
• Subjects: 간호학; 옥살리플라틴; 말초신경병증; Oxaliplatin; 항암화학요법; Distress; Peripheral neuropathy; Symptom; 삶의 질; Quality of life; 위장관암
• ISSN: 2287-2434; 2287-447X
• DOI: 10.5388/aon.2019.19.4.204

Purpose: This study was conducted to identify the level of oxaliplatin-induced peripheral neuropathy (OIPN), symptoms, distress, and quality of life (QoL) in gastrointestinal (GI) cancer patients and to identify the factors influencing QoL. Methods: A total of 123 patients were recruited for this cross-sectional study. Surveys used were the Therapy-Induced Neuropathy Assessment Scale (TNAS) for OIPN, the MD Anderson Symptom Inventory (MDASI-GI) for general symptoms associated with gastrointestinal cancer and its treatment, a distress thermometer, and the Euro Quality of Life Questionnaire 5-Dimensional Classification (EQ-5D) for QoL. Results: The patients were classified into three groups based on their treatment completion time (current, completed less than one year ago, completed more than one year ago). The scores of MDASI-GI and distress were significantly lower in patients who had completed chemotherapy compared to those who were undergoing treatment (p=.04 and .02 respectively). However, TNAS score was significantly higher in patients who completed chemotherapy less than one year ago than the other two groups (p=.001). In multivariate regression models, the OIPN and distress or general symptoms were identified as factors associated with QoL. Conclusion: In this study, we identified the symptoms that are factors related to the QoL in patients with GI cancer. In particular, the symptoms of OIPN are reported at significantly increased levels for patients who have finished chemotherapy less than one year ago, so efforts to prevent and manage the symptoms of OIPN are needed in this timeframe. To improve QoL of patients with GI cancer, continuous attention and care are required not only during the treatment of cancer but also after the completion of treatment. KCI Citation Count: 1